Physiological reactions in virtual reality in acrophobia

Not Applicable

• Conditions: F40.2; Specific (isolated) phobias

• Registration Number: DRKS00000747
• Lead Sponsor: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Münster

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-03-04
• Study Completion: 2013-11-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 102

Inclusion Criteria

65 patients with acrophobia; 40 healthy matched controls

Exclusion Criteria

•psychiatric disorder other than secific phobia (comorbidity according to DSM-IV-TR)
•acute suicidal intent
•epilepsy or other illness of the central nervous system (brain tumor, encephalitis)
•migraine
•concomitant psychotherapy
•concomitant medication with psychotropic drugs
•pregnancy
•history of heart disease or psychotic disorder

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of acophobic symptoms, evalued wiht Acrophobia Questionnaire (before and after each of the 3 exposures) and SUDS (Subjective Units of Discomfort; assessed during each of the 3 exposures)<br>

Secondary Outcome Measures

Name	Time	Method
Strength of autonomic arousal measured by the following pysiological measures: salivary Cortisol (during 1. exposure), heart rate and electrodermal activity (measured during all 3 exposures). <br>In patients: Severity of height avoidance, measured by Behavioural Avoidance Test (before 2. and after 3. exposure).